Home > Insider Trading > Filing (0001225208-13-012562)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
78003	Pfizer Inc	PFE	Pharmaceutical Preparations (2834)	135315170

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1194004	A Frank Damelio	Pfizer Inc.-Corp. Secretary 235 East 42Nd St. New York NY 10017	Executive Vice President	No	Yes	No	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership
Common Stock	Disposition	2013-05-15	100	$29.42	585,582	No	4	S	Direct
Common Stock	Disposition	2013-05-15	100	$29.38	585,482	No	4	S	Direct
Common Stock	Disposition	2013-05-15	200	$29.24	585,282	No	4	S	Direct
Common Stock	Disposition	2013-05-15	900	$29.28	584,382	No	4	S	Direct
Common Stock	Disposition	2013-05-15	1,700	$29.26	582,682	No	4	S	Direct
Common Stock	Disposition	2013-05-15	2,200	$29.23	580,482	No	4	S	Direct
Common Stock	Disposition	2013-05-15	2,400	$29.37	578,082	No	4	S	Direct
Common Stock	Disposition	2013-05-15	2,400	$29.25	575,682	No	4	S	Direct
Common Stock	Disposition	2013-05-15	2,447	$29.27	573,235	No	4	S	Direct
Common Stock	Disposition	2013-05-15	2,700	$29.40	570,535	No	4	S	Direct
Common Stock	Disposition	2013-05-15	3,500	$29.39	567,035	No	4	S	Direct
Common Stock	Disposition	2013-05-15	4,745	$29.29	562,290	No	4	S	Direct
Common Stock	Disposition	2013-05-15	5,103	$29.36	557,187	No	4	S	Direct
Common Stock	Disposition	2013-05-15	5,693	$29.31	551,494	No	4	S	Direct
Common Stock	Disposition	2013-05-15	6,342	$29.41	545,152	No	4	S	Direct
Common Stock	Disposition	2013-05-15	8,106	$29.34	537,046	No	4	S	Direct
Common Stock	Disposition	2013-05-15	10,913	$29.33	526,133	No	4	S	Direct
Common Stock	Disposition	2013-05-15	11,706	$29.35	514,427	No	4	S	Direct
Common Stock	Disposition	2013-05-15	14,248	$29.32	500,179	No	4	S	Direct
Common Stock	Disposition	2013-05-15	14,497	$29.30	485,682	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct

Reported Derivative Transactions

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Phantom Stock Units SSP	Acquisiton	2013-05-15	319	$29.56	319	$0.00

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
30,084			No	4	A	Direct

Reported Non-Derivative Holdings

Sec. Name	Remaning Holdings	Nature of Ownership	Explanation
Common Stock	3,886	Indirect	By Rule 16b-3 Plan

Footnotes

This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 14, 2013.
Each unit represents one phantom share of common stock.
These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment account at any time.